Abstract
Background and purpose
Lactate was previously shown to be a prognostic but not a predictive pre-therapeutic marker for radiation response of tumor xenografts. We hypothesize that metabolic changes during fractionated irradiation may restrict the predictiveness of lactate regarding tumor radiosensitivity.
Materials and methods
Tumor xenografts were generated in nude mice by implanting 4 head and neck squamous cell carcinoma lines with different sensitivities to fractionated irradiation. Tumors were irradiated with up to 15 fractions of 2 Gy over a period of 3 weeks, and ATP and lactate levels were measured in vital tumor areas with induced metabolic bioluminescence imaging. Corresponding changes in mRNA expression of glycolysis-related genes were determined by quantitative RT-PCR.
Results
Lactate content decreased significantly in 3 out of 4 cell lines in the course of irradiation showing no correlation with cell line-specific radiosensitivity. Radiation-induced changes in ATP levels and glycolysis-related mRNA expression, however, only occurred in radiosensitive or intermediately radioresistant xenografts, whereas these parameters remained unchanged in radioresistant tumors.
Conclusion
Sensitivity-related differences in the transcriptional response of tumors to radiotherapy may be exploited in the clinic for better individualization of tumor treatment.
Zusammenfassung
Hintergrund und Fragestellung
Der Laktatgehalt humaner Tumorxenotransplantate ist ein prognostischer, aber kein prädiktiver prätherapeutischer Marker für das Therapieansprechen bei Bestrahlung. Diese Einschränkung hinsichtlich der Vorhersagekraft von Laktat könnte auf Veränderungen des Tumorstoffwechsels während einer Strahlentherapie beruhen.
Material und Methode
Grundlage der Studie waren Xenotransplantate von 4 humanen Plattenepithelkarzinomlinien des Kopf-Hals-Bereichs, die sich in ihrer Strahlenresistenz unterschieden. Die Tumoren wurden mit bis zu 15 Fraktionen mit 2 Gy über einen Zeitraum von 3 Wochen bestrahlt. Mittels induzierter metabolischer Biolumineszenzmessung wurden der ATP- und Laktatgehalt im vitalen Tumorgewebe bestimmt. Zusätzlich erfolgten Messungen der parallelen Veränderungen der mRNA-Expression glykolyserelevanter Gene mit quantitativer RT-PCR.
Ergebnisse
Unabhängig von der zelllinienspezifischen Strahlenresistenz nahm in 3 von 4 Linien der Laktatgehalt im Laufe der fraktionierten Bestrahlung ab. Strahleninduzierte Änderungen des ATP-Gehalts oder der mRNA-Expression waren hingegen mit der Strahlensensitivität der jeweiligen Tumore korreliert. Im Gegensatz zu strahlenresistenten Xenografts zeigten radiosensitive Tumore oder Xenotransplantate mit einer mittleren Strahlenresistenz signifikante Änderungen im ATP-Gehalt und auf transkriptioneller Ebene.
Schlussfolgerung
Die Ergebnisse weisen auf Unterschiede in der transkriptionellen Antwort der Tumoren nach Bestrahlung hin, die sich im klinischen Alltag für eine bessere personalisierte Tumorbehandlung nutzen lassen könnten.
References
Altenberg B, Greulich KO (2004) Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics 84:1014–1020
Bernier J, Horiot JC (2012) Altered-fractionated radiotherapy in locally advanced head and neck cancer. Curr Opin Oncol 24:223–228
Broggini-Tenzer A, Vuong V, Pruschy M (2011) Metabolism of tumors under treatment: mapping of metabolites with quantitative bioluminescence. Radiother Oncol 99:398–403
Eicheler W, Zips D, Dorfler A et al (2002) Splicing mutations in TP53 in human squamous cell carcinoma lines influence immunohistochemical detection. J Histochem Cytochem 50:197–204
Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4:891–899
Hirschhaeuser F, Sattler UG, Mueller-Klieser W (2011) Lactate: a metabolic key player in cancer. Cancer Res 71:6921–6925
Lee SC, Poptani H, Pickup S et al (2010) Early detection of radiation therapy response in non-Hodgkin’s lymphoma xenografts by in vivo 1H magnetic resonance spectroscopy and imaging. NMR Biomed 23:624–632
Moreno-Sanchez R, Rodriguez-Enriquez S, Marin-Hernandez A, Saavedra E (2007) Energy metabolism in tumor cells. FEBS J 274:1393–1418
Romero-Garcia S, Lopez-Gonzalez JS, Baez-Viveros JL et al (2011) Tumor cell metabolism: an integral view. Cancer Biol Ther 12:939–948
Sattler UG, Meyer SS, Quennet V et al (2010) Glycolytic metabolism and tumour response to fractionated irradiation. Radiother Oncol 94:102–109
Thews O, Zywietz F, Lecher B, Vaupel P (1999) Quantitative changes of metabolic and bioenergetic parameters in experimental tumors during fractionated irradiation. Int J Radiat Oncol Biol Phys 45:1281–1288
Tozer G, Suit HD, Barlai-Kovach M et al (1987) Energy metabolism and blood perfusion in a mouse mammary adenocarcinoma during growth and following X irradiation. Radiat Res 109:275–293
Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029–1033
Walenta S, Mueller-Klieser WF (2004) Lactate: mirror and motor of tumor malignancy. Semin Radiat Oncol 14:267–274
Warburg O (1956) On the origin of cancer cells. Science 123:309–314
Yaromina A, Krause M, Thames H et al (2007) Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation. Radiother Oncol 83:304–310
Yaromina A, Kroeber T, Meinzer A et al (2011) Exploratory study of the prognostic value of microenvironmental parameters during fractionated irradiation in human squamous cell carcinoma xenografts. Int J Radiat Oncol Biol Phys 80:1205–1213
Yaromina A, Zips D, Thames HD et al (2006) Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies. Radiother Oncol 81:122–129
Ziebart T, Walenta S, Sattler U et al (2010) Metabolite-induced bioluminescence for tumor prediction: detection of metabolites in tumors of the head and neck region. HNO 58:31–34
Zips D, Boke S, Kroeber T et al (2011) Prognostic value of radiobiological hypoxia during fractionated irradiation for local tumor control. Strahlenther Onkol 187:306–310
Conflict of interest
On behalf of all authors, the corresponding author states that there are no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Goetze, K., Meyer, S., Yaromina, A. et al. Glycolysis-related gene induction and ATP reduction during fractionated irradiation. Strahlenther Onkol 189, 782–788 (2013). https://doi.org/10.1007/s00066-013-0371-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00066-013-0371-9
Keywords
- Glucose metabolism
- Transplantation, heterologous
- Carcinoma, squamous cell
- mRNA expression
- Induced metabolic bioluminescence imaging